Bernardo, Judith R.
HRN: 22-55-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/12/2023
02/19/2023
IV
500mg
Q8
Perianal Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes